Form 13-F position report

Y-MABS THERAPEUTICS INC

Reported by BROOKFIELD CORPORATION

YMAB CUSIP 984241109 Manager CIK 0001001085

Reported 0 shares, down 179,236 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2021
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 5 Through Q4 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

1 quarter
Quarterly reported position history for Y-MABS THERAPEUTICS INC held by BROOKFIELD CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2021 Reduced 0 -179,236 (-100.0%) 0 $0 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

110 managers reported Y-MABS THERAPEUTICS INC for Q4 2021.

Managers reporting Y-MABS THERAPEUTICS INC in Q4 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
WELLINGTON MANAGEMENT GROUP LLP Reduced 4,271,382 -6,715 0.01% $69,239,000 10 qtrs
BlackRock Inc Added 2,767,360 +30,500 < 0.01% $44,859,000 14 qtrs
Sofinnova Investments Inc Unchanged 2,194,278 0 2.08% $35,569,000 14 qtrs
ALLIANCEBERNSTEIN L P Added 1,942,334 +524,525 0.01% $31,485,000 14 qtrs
VANGUARD GROUP INC Added 1,817,074 +13,150 < 0.01% $29,455,000 14 qtrs
Artisan Partners Limited Partnership Reduced 1,581,845 -106,711 0.03% $25,642,000 8 qtrs
FMR LLC Unchanged 1,525,787 0 < 0.01% $24,733,000 14 qtrs
STATE STREET CORPORATION Added 1,456,670 +124,727 < 0.01% $23,613,000 13 qtrs
Polar Capital Holdings Plc Added 1,377,671 +222,710 0.08% $22,332,000 5 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 620,977 +43,866 < 0.01% $10,066,000 13 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2021
Filed
February 14, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.